Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...